Safety of continuous use of Apixaban, Rivaroxaban and Dabigatran in patients undergoing cardiac implantable electronic device implantation in a real-world cohort
27 August 2018 (08:30 - 12:30)
Organised by:
Abstract
About the speaker
Charite University Hospital, Berlin (Germany)
6 More presentations in this session
Access the full session
The Event
ESC Congress 2018
27 August 2018
08:30 CET
You may be interested in
Congress Session
Congress Session
